LivaNova PLC (LIVN)

Market Cap	2.52B
Revenue (ttm)	1.05B
Net Income (ttm)	-81.87M
Shares Out	53.77M
EPS (ttm)	-1.54
PE Ratio	n/a
Forward PE	24.45
Dividend	n/a
Ex-Dividend Date	n/a

Volume	297,689
Open	46.08
Previous Close	45.60
Day's Range	45.84 - 46.92
52-Week Range	40.26 - 70.57
Beta	0.86
Analysts	Buy
Price Target	56.25 (+20.06%)
Earnings Date	May 3, 2023

About LIVN

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. It operates through three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, and markets VNS Therapy System, an implantable device tha...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Feb 10, 1993
• Employees: 2,900
• Stock Exchange: NASDAQ
• Ticker Symbol: LIVN

Financial Performance

In 2022, LivaNova's revenue was $1.02 billion, a decrease of -1.31% compared to the previous year's $1.04 billion. Losses were -$86.25 million, -36.50% less than in 2021.

Analyst Forecast

According to 4 analysts, the average rating for LIVN stock is "Buy." The 12-month stock price forecast is $56.25, which is an increase of 20.06% from the latest price.

Price Target

$56.25

(20.06% upside)

Analyst Consensus: Buy